Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats

Brain Research

Volumn 1642, Issue , 2016, Pages 389-396

  Marszalek Grabska, M ^a   Gibula Bruzda, E ^a   Jenda, M ^a   Gawel, K ^a   Kotlinska, J H ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amphetamine withdrawal; Forced swim test; Memantine; Novel object recognition test; Rats

Indexed keywords

AMPHETAMINE; DIZOCILPINE; IMIPRAMINE; MEMANTINE; SCOPOLAMINE; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; DIZOCILPINE MALEATE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOOTROPIC AGENT; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; FORCED SWIM TEST; IMMOBILITY; LOCOMOTION; MEMORY DISORDER; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; RAT; RECOGNITION; AMPHETAMINE-RELATED DISORDERS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MALE; MEMORY DISORDERS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME; WISTAR RAT;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; IMIPRAMINE; MALE; MEMANTINE; MEMORY DISORDERS; MUSCARINIC ANTAGONISTS; NOOTROPIC AGENTS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE HYDROBROMIDE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84964294533     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.04.026     Document Type: Article

References (79)

1. N.A. Addy, E.J. Nunes, and R.J. Wickham Ventral tagmental area cholinergic mechanisms mediate behavioral responses in the forced swim test Behav. Brain Res. 288 2015 54 62
2. E. Aharonovich, F. Garawi, A. Bisaga, D. Brooks, W.N. Raby, E. Rubin, E.V. Nunes, and F.R. Levin Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome Am. J. Drug. Alcohol Abus. 32 2006 629 635
3. R.C. Almeida, C.S. Felisbino, M.G. Lopez, A.L.S. Rodrigues, and N.H. Gabilan Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant- like effect of memantine in mice Behav. Brain Res. 168 2006 318 322
4. Y. Aracava, E.F. Pereira, A. Maelicke, and E.X. Albuquerque Memantine blocks alpha 7 nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons J Pharmacol. Exp. Ther. 313 2005 928 929
5. M. Bagheri, A. Mokri, A. Khosravi, and K. Kabir Effect of abstinence on depression, anxiety, and quality of life in chronic methamphetamine users in a therapeutic community Int. J. High Risk Behav. Addict. 4 2015 e23903
6. A.M. Barr, A. Markou, and A.G. Phillips A 'crash' course on psychostimulant withdrawal as a model of depression Trends Pharmacol. Sci. 23 2002 475 482
7. A.M. Barr, and A. Markou Psychostimulant withdrawal as an inducing condition in animal models of depression Neurosci. Biobehav. Rev. 29 2005 675 706
8. R.M. Berman, A. Cappiello, A. Anand, D. Oren, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 47 2000 351 354
9. T.V.P. Bliss, and A.R. Gardner-Medwin Long-lasting potentiation of synaptic transmission in the dentate area of the unanesthetized rabbit following stimulation of the perforant path J Physiol. 232 1973 357 374
10. R.A. Bressan, and J.A. Crippa The role of dopamine in reward and pleasure behaviour - review of data from preclinical research Acta Psychiatr. Scand. Suppl. 111 2005 14 21
11. J. Camarasa, T. Rodrigo, D. Pubill, and E. Escubedo Memantine is a useful drug to prevent the spatial and non-spatial memory deficits by methamphetamine in rats Pharmacol. Res. 62 2010 450 456
12. Y. Che, Y.-H. Cui, H. Tan, A.C. Andreazza, L.T. Young, and J.-F. Wang Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain Psychopharmacology 227 2013 605 614
13. H.S. Chen, and S.A. Lipton The chemical biology of clinically tolerated NMDA receptor antagonists J. Neurochem. 97 2006 1611 1626
14. P.E. Croarkin, P.A. Nakonezny, M.M. Husain, T. Melton, J.S. Buyukdura, B.D. Kennard, G.J. Emslie, F.A. Kozel, and Z.J. Daskalakis Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder JAMA Psychiatry 1 2013 291 299
15. F. Dajas-Bailador, and S. Wonnacott Nicotinic acetylcholine receptors and the regulation of neuronal signaling Trends Pharm. Sci. 25 2004 317 324
16. W. Danysz, C.G. Parsons, J. Kornhuber, W.J. Schmidt, and G. Quack Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies Neurosci. Biobehav. Rev. 21 1997 455 468
17. A. Del Arco, R. Martinez, and F. Mora Amphetamine increases extracellular concentrations of glutamate in the prefrontal cortex of the awake rats: a microdialysis study Neurochem. Res. 23 1998 1153 1158
18. B.D. Drever, W.G.L. Anderson, H. Johnson, M. O'Callaghan, A. Seo, D.Y. Choi, G. Riedel, and B. Platt Memantine acts as a cholinergic stimulant in the mouse hippocampus J Alzheimers Dis. 12 2007 319 333
19. W.C. Drevets, C. Gautier, J.C. Price, P.E. Kupfer, P.E. Kinahan, A.A. Grace, J.L. Price, and C.A. Mathis Amphetamine induced dopamine release in human ventral striatum correlates with euphoria Biol. Psychiatry 49 2001 81 96
20. M.S. D'Souza, and A. Markou Neural substrates of psychostimulant withdrawal-induced anhedonia Curr. Top. Behav. Neurosci. 3 2010 119 178
21. T. Egashira, and Y. Yamanaka Changes in monoamin oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal Biochem. Pharmacol. 46 1993 609 614
22. M. Emre, P. Mecocci, and K. Stender Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease J. Alzheimers Dis. 14 2008 193 199
23. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data Behav. Brain Res. 31 1988 47 59
24. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu. Rev. Pharmacol. Toxicol. 47 2007 681 698
25. M.L. Furey, and W.C. Drevets Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial Arch. Gen. Psychiatry 63 2006 1121 1129
26. J.T. Gass, and M.F. Olive Glutamatergic substrates of drug addiction and alcoholism Biochem. Pharmacol. 75 2008 218 265
27. S. Glasner-Edwards, L.J. Mooney, P. Marinelli-Casey, M. Hillhouse, A. Ang, and R. Rawson Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning Methamphetamine Treatment Project Corporate Authors Am. J. Addict. 19 2010 385 390
28. C.L. Goncalves, C.B. Furlanetto, S.S. Valvassori, D.V. Bavaresco, R.B. Varela, J. Budni, J. Quevedo, and E.L. Streck Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors Metab. Brain Dis. 30 2015 583 588
29. L.L. Howell, and H.L. Kimmel Monoamine transporters and psychostimulant addiction Biochem. Pharmacol. 75 2008 196 217
30. P.H. Hutson, F.I. Tarazi, M. Madhoo, C. Slawecki, and A.A. Patkar Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders Pharmacol. Ther. 143 2014 253 264
31. J. Ihalainen, T. Sarajärvi, D. Rasmusson, S. Kemppainen, P. Keski-Rahkonen, M. Lehtonen, P.K. Banerjee, K. Semba, and H. Tanila Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats Neuropharmacology 61 2011 891 899
32. J.E. Iudicello, S.P. Woods, O. Vigil, J.C. Scott, M. Cherner, R.K. Heaton, and J.H. Atkinson Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence Grant, I., HIV Neurobehavioral Research Center (HNRC) Group J. Clin. Exp. Neuropsychol. 32 2010 704 718
33. D. Jacobs, and T. Silverstone Dextroamphetamine - induced arousal in human subjects as a model for mania Psychol. Med. 16 1986 323 329
34. J.D. Jentsch, P. Olausson, H.R. De La Garza, and J.R. Taylor Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administration to monkeys Neuropsychopharmacology 26 2002 183 190
35. C.J. Jordan, D.M. Taylor, L.P. Dwoskin, and K.M. Kantak Adolescent d-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood Behav. Brain 297 2015 165 179
36. P.W. Kalivas Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity Dialog-. Clin. Neurosci. 9 2007 389 397
37. T. Kato, T. Kasahara, M. Kubota-Sakashita, T.M. Kato, and K. Nakajima Animal models of recurrent or bipolar depression Neuroscience 2015 10.1016/j.neuroscience
38. S.F. Kendell, J.H. Krystal, and G. Sanacora GABA and glutamate systems as therapeutic targets in depression and mood disorders Expert. Opin. Ther. Targets 9 2005 153 168
39. P.J. Kenny, and A. Markou Neurobiology of the nicotine withdrawal syndrome Pharmacol. Biochem. Behav. 70 2001 531 549
40. J.A. Lago, and T.R. Kosten Stimulant withdrawal Addiction 89 1994 1477 1481
41. W. Lu, and M.E. Wolf Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration Mol. Brain Res. 49 1997 137 148
42. R.C. Malenka, and M.F. Bear LTP and LTD: an embarrassment of riches Neuron 44 2004 5 21
43. Y.S. Mineur, A. Obayemi, M.B. Wigestrand, G.M. Fote, C.A. Calarco, A.M. Li, and M.R. Picciotto Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior Proc. Natl. Acad. Sci. USA 110 2013 3573 3578
44. M. Misztal, and W. Danysz Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidance Behav. Pharmacol. 6 1995 550 561
45. C. McGregor, M. Srisurapanont, J. Jittiwutikarn, S. Laobhripatr, T. Wongtan, and J.M. White The nature, time course and severity of methamphetamine withdrawal Addiction 100 2005 1320 1329
46. E.J. Nestler, and W.A. Carlezon Jr The mesolimbic dopamine reward circuit in depression Biol. Psychiatry 59 2006 1151 1159
47. F. Nyberg Structural plasticity of the brain to psychostimulant use Neuropharmacology 87 2014 115 124
48. R. Ostroff, M. Gonzales, and G. Sanacora Antidepressant effect of ketamine during ECT Am. J. Psychiatry 162 2005 1385 1386
49. C.G. Parsons, W. Danysz, and G. Quack Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data Neuropharmacology 38 1999 735 767
50. C.G. Parsons, A. Stöffler, and W. Danysz Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse Neuropsychopharmacology 53 2007 699 723
51. I.A. Paul, and P. Skolnick Glutamate and depression: clinical and preclinical studies Ann. NY Acad. Sci. 1003 2003 250 272
52. E.R. Peskind, S.G. Potkin, N. Pomara, B.R. Ott, S.M. Graham, J.T. Olin, and S. McDonald Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial Am. J Geriatr. Psychiatry 14 2006 704 715
53. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47 1978 379 391
54. G. Rammes, M. Palmer, M. Eder, H.U. Dodt, W. Zieglgänsberger, and G.L. Collingridge Activation of mGlu receptors induces LTD without affecting postsynaptic sensitivity of CA1 neurons in rat hippocampal slices J. Physiol. 546 2003 455 460
55. G. Rammes, W. Danysz, and C.G. Parsons Pharmacodynamics of memantine: an update Curr. Neuropharmacol. 6 2008 55 78
56. M. Reske, C.A. Eidt, D.C. Delis, and M.P. Paulus Nondependent stimulant users of cocaine and prescription amphetamine show verbal learning and memory deficits Biol. Psychiatry 68 2010 762 769
57. G.Z. Réus, R.B. Stringari, T. Kirsch, G.R. Fries, F. Kapczinski, R. Roesler, and J. Quevedo Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res. Bull. 81 2010 585 589
58. G.Z. Réus, H.M. Abelaira, R.B. Stringari, G.R. Fries, F. Kapczinski, and J. Quevedo Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats Metab. Brain Dis. 27 2012 175 182
59. E. Richelson, and M. Pfenning Blockade by antidepressant and related compounds of biogenic amine uptake into rat brain synaptosomes; antidepressants selectively block norepinephrine uptake Eur. J. Pharmacol. 104 1984 277 286
60. J.B. Robinson Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl Biochem. Pharmacol. 34 1985 4105 4108
61. M.A. Rogowski, and G.L. Wenk The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease CNS Drug. Rev. 9 2003 275 308
62. Z. Rogóz, G. Skuza, J. Maj, and W. Danysz Synergistic effect of uncompetitive NMDA receptor antagonist and antidepressant drugs in the forced swimming test in rats Neuropharmacology 42 2002 1024 1030
63. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.J. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nature 7 2008 426 437
64. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
65. E. Scarpini, P. Scheltens, and H. Feldman Treatment of Alzheimer's disease: current status and new perspectives Lancet Neurol. 2 2003 539 547
66. G. Schoenbaum, M.P. Saddoris, S.J. Ramus, Y. Shaham, and B. Setlow Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions Eur. J Neurosci. 19 2004 1997 2002
67. E. Shearman, S. Rossi, B. Szasz, Z. Juranyi, S. Fallon, N. Pomara, H. Sershen, and A. Lajtha Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study Brain Res. Bull. 69 2006 204 213
68. P. Skolnick, P. Popik, and R. Trullas Glutamate-based antidepressants: 20 years on Trends Pharmacol. Sci. 30 2009 563 569
69. P. Skolnick, T. Kos, J. Czekaj, and P. Popik Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test Acta Neuropsychiatr. 27 2015 228 234
70. G. Skuza, and Z. Rogóz Sigma 1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats Pol. J. Pharmacol. 55 2003 1149 1152
71. M. Srisurapanont, R. Ali, J. Marsden, A. Sunga, K. Wada, and M. Monteiro Psychotic symptoms in methamphetamine psychotic in-patients Int. J. Neuropsychopharmacol. 6 2003 347 352
72. K. Tokita, Y. Fujita, T. Yamaji, and K. Hashimoto Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine Pharmacol. Biochem. Behav. 102 2012 329 334
73. M. Valenza, L. Steardo, P. Cottone, and V. Sabino Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of d-amphetamine Psychopharmacol. (Berl.) 232 2015 3215 3226
74. A. Volianskis, G. France, M.S. Jensen, Z.A. Bortolotto, D.E. Jane, and G.L. Collingridge Long-term potentiation and the role of N-methyl-d-aspartate receptors Brain Res. 2015 10.1016/j.brainres.2015.01.016
75. B.D. Winters, L.M. Saksida, and T.J. Bussey Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval Neurosci. Biobehav. Rev. 32 2008 1055 1070
76. C.J. Xue, J.P. Ng, Y. Li, and M.E. Wolf Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens J Neurochem. 67 1996 352 363
77. N.R. Zahniser, and A. Sorkin Trafficking of dopamine transporters in psychostimulant actions Semin. Cell Dev. Biol. 20 2009 411 417
78. W. Zajaczkowski, G. Quack, and W. Danysz Infusion of (±)-MK-801 and memantine: contrasting effects on radial maze learning in rats with entorhinal cortex lesion Eur. J Pharmacol. 296 1996 239 246
79. T. Zorick, L. Nestor, K. Miotto, C. Sugar, G. Hellemann, G. Scanlon, R. Rawson, and E.D. London Withdrawal symptoms in abstinent methamphetamine-dependent subjects Addiction 105 2010 1809 1818